Zobrazeno 1 - 9 of 9 pro vyhledávání: '"R T, Webb"'
1
Akademický článek
Absolute risks of self-harm and interpersonal violence by diagnostic category following first discharge from inpatient psychiatric care
Autor: P. L. H. Mok, F. Walter, M. J. Carr, S. Antonsen, N. Kapur, S. Steeg, J. Shaw, C. B. Pedersen, R. T. Webb
Publikováno v: European Psychiatry, Vol 66 (2023)
Abstract Background Persons discharged from inpatient psychiatric services are at greatly elevated risk of harming themselves or inflicting violence on others, but no studies have reported gender-specific absolute risks for these two outcomes across
Externí odkaz: https://doaj.org/article/b1bf27196bad4a498ca0f840793a222b
Zobrazit plný text záznamu
3
Stage III and stage IV non-small cell carcinoma patients triple chemotherapy combination (carboplatin, paclitaxel, and gemcitabine) in good performance status
Autor: R. T. Webb, L. M. Gill
Publikováno v: Journal of Clinical Oncology. 25:18205-18205
18205 Background: Triple drug chemotherapy combinations for nonsmall cell lung cancer (NSCLC) have most recently begun to show promising results in regards to response rate and time to progression (TTP) of disease. This abstract presents data from 99
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::59b4614ea448c7afb6e1a5ede5c5624c
https://doi.org/10.1200/jco.2007.25.18_suppl.18205
Zobrazit plný text záznamu
4
A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)
Autor: W. Khan, J. P. Allerton, T. F. Goggins, C. T. Hagenstad, S. B. Katakkar, R. T. Webb, F. A. Greco, N. D. Mehta, G. B. Smith, R. Birch
Publikováno v: Journal of Clinical Oncology. 24:7127-7127
7127 Background: Abraxane (A) is a cremophor free, albumin-bound nanoparticle of paclitaxel (P) approved for the treatment of metastatic breast cancer. Belani et al. (JCO 21: 2933–2939, 2003) reported that P 100 mg/m2 days 1, 8 and 15 q 28 days wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::228a9bd78249ac103265991210da4778
https://doi.org/10.1200/jco.2006.24.18_suppl.7127
Zobrazit plný text záznamu
5
Randomized Phase II Study of the Neurokinin 1 Receptor Antagonist CJ-11,974 in the Control of Cisplatin-Induced Emesis
Autor: C. B. Stack, S. DelPrete, M. E. Bachinsky, W. Ueno, Richard J. Gralla, R. T. Webb, Paul J. Hesketh, S. L. Silberman, N. L. Dirlam
Publikováno v: Journal of Clinical Oncology. 17:338-338
PURPOSE: To determine the efficacy and safety of the neurokinin type 1 receptor antagonist CJ-11,974 for the control of high-dose cisplatin-induced emesis. PATIENTS AND METHODS: A double-blind, randomized, phase II design with a group sequential stop
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f42541d47145711fe1643acd24f20f
https://doi.org/10.1200/jco.1999.17.1.338
Zobrazit plný text záznamu
6
Penetrating Duodenal Ulcer from Hepatic Artery Chemotherapy Infusion Catheter
Autor: Farhad Navab, T. J. Ortego, L. F. Hutchins, R. T. Webb, N P Lang
Publikováno v: Journal of Clinical Gastroenterology. 10:434-436
A 45-year-old woman receiving continuous infusions of 5-fluoro-2'-deoxy-uridine into the hepatic artery through a surgically implanted intraarterial catheter for hepatic metastases from adenocarcinoma of the colon, developed acute epigastric pain and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12aadc686a9fcd0ba014b29a47bd3bb2
https://doi.org/10.1097/00004836-198808000-00016
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje